Register to attend this webinar HERE
Join us September 21st for an introduction of the Xeljanz litigation. Just recently, the FDA found that there are serious risks associated with Xeljanz. The Xeljanz webinar will discuss the nature of these findings and the range of injuries that we expect to see in this litigation. If you are looking for something new, this is a session you don’t want to miss!